CH616435A5 - - Google Patents
Download PDFInfo
- Publication number
- CH616435A5 CH616435A5 CH1314375A CH1314375A CH616435A5 CH 616435 A5 CH616435 A5 CH 616435A5 CH 1314375 A CH1314375 A CH 1314375A CH 1314375 A CH1314375 A CH 1314375A CH 616435 A5 CH616435 A5 CH 616435A5
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- general formula
- compounds
- methyl
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2448662A DE2448662C2 (de) | 1974-10-09 | 1974-10-09 | 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH616435A5 true CH616435A5 (fr) | 1980-03-31 |
Family
ID=5928132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1314375A CH616435A5 (fr) | 1974-10-09 | 1975-10-09 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4008313A (fr) |
| JP (1) | JPS5163166A (fr) |
| AT (1) | AT345485B (fr) |
| AU (1) | AU507129B2 (fr) |
| BE (1) | BE834347A (fr) |
| CA (1) | CA1040191A (fr) |
| CH (1) | CH616435A5 (fr) |
| CS (1) | CS182294B2 (fr) |
| DD (1) | DD123328A5 (fr) |
| DE (1) | DE2448662C2 (fr) |
| DK (1) | DK138500C (fr) |
| ES (1) | ES441639A1 (fr) |
| FR (1) | FR2287232A1 (fr) |
| GB (1) | GB1527249A (fr) |
| HU (1) | HU173116B (fr) |
| IE (1) | IE42283B1 (fr) |
| IL (1) | IL48208A (fr) |
| NL (1) | NL7511831A (fr) |
| SE (1) | SE407580B (fr) |
| SU (1) | SU818488A3 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7802905A (nl) * | 1977-04-21 | 1978-10-24 | Hoffmann La Roche | Werkwijze voor het bereiden van d-homosteroiden. |
| US8729108B2 (en) * | 2008-06-17 | 2014-05-20 | Christopher J Dannaker | Waterborne topical compositions for the delivery of active ingredients such as azelaic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2059310C3 (de) * | 1970-11-28 | 1980-10-30 | Schering Ag | diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung |
| GB1440064A (en) * | 1972-08-11 | 1976-06-23 | Glaxo Lab Ltd | Delta8-9- steroids of the pregnane series |
-
1974
- 1974-10-09 DE DE2448662A patent/DE2448662C2/de not_active Expired
-
1975
- 1975-09-30 IL IL48208A patent/IL48208A/xx unknown
- 1975-10-03 SU SU752177211A patent/SU818488A3/ru active
- 1975-10-03 DD DD188715A patent/DD123328A5/xx unknown
- 1975-10-06 CS CS7500006758A patent/CS182294B2/cs unknown
- 1975-10-07 US US05/620,411 patent/US4008313A/en not_active Expired - Lifetime
- 1975-10-08 HU HU75SC538A patent/HU173116B/hu unknown
- 1975-10-08 SE SE7511266A patent/SE407580B/xx unknown
- 1975-10-08 AU AU85568/75A patent/AU507129B2/en not_active Expired
- 1975-10-08 NL NL7511831A patent/NL7511831A/xx not_active Application Discontinuation
- 1975-10-08 CA CA237,236A patent/CA1040191A/fr not_active Expired
- 1975-10-09 IE IE2207/75A patent/IE42283B1/en unknown
- 1975-10-09 BE BE160810A patent/BE834347A/fr unknown
- 1975-10-09 ES ES441639A patent/ES441639A1/es not_active Expired
- 1975-10-09 DK DK455275A patent/DK138500C/da not_active IP Right Cessation
- 1975-10-09 JP JP50122361A patent/JPS5163166A/ja active Pending
- 1975-10-09 GB GB41420/75A patent/GB1527249A/en not_active Expired
- 1975-10-09 FR FR7530926A patent/FR2287232A1/fr active Granted
- 1975-10-09 CH CH1314375A patent/CH616435A5/de not_active IP Right Cessation
- 1975-10-09 AT AT771975A patent/AT345485B/de active
Also Published As
| Publication number | Publication date |
|---|---|
| DK455275A (da) | 1976-04-10 |
| ATA771975A (de) | 1978-01-15 |
| CS182294B2 (en) | 1978-04-28 |
| FR2287232A1 (fr) | 1976-05-07 |
| BE834347A (fr) | 1976-04-09 |
| DK138500C (da) | 1979-02-26 |
| AU8556875A (en) | 1977-04-21 |
| US4008313A (en) | 1977-02-15 |
| SE7511266L (sv) | 1976-04-12 |
| NL7511831A (nl) | 1976-04-13 |
| AT345485B (de) | 1978-09-25 |
| HU173116B (hu) | 1979-02-28 |
| FR2287232B1 (fr) | 1980-05-09 |
| IL48208A0 (en) | 1975-11-25 |
| IL48208A (en) | 1979-01-31 |
| IE42283L (en) | 1976-04-09 |
| AU507129B2 (en) | 1980-02-07 |
| JPS5163166A (fr) | 1976-06-01 |
| GB1527249A (en) | 1978-10-04 |
| DE2448662A1 (de) | 1976-04-22 |
| SU818488A3 (ru) | 1981-03-30 |
| DE2448662C2 (de) | 1983-07-21 |
| DD123328A5 (fr) | 1976-12-12 |
| CA1040191A (fr) | 1978-10-10 |
| IE42283B1 (en) | 1980-07-16 |
| SE407580B (sv) | 1979-04-02 |
| ES441639A1 (es) | 1977-04-01 |
| DK138500B (da) | 1978-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0072547B1 (fr) | Dérivés de 6-alpha-méthyl prednisolone, leur préparation et leur utilisation | |
| CH540244A (de) | Verfahren zur Herstellung neuer Halogenpregnadiene | |
| EP0110041B1 (fr) | 6-Alpha méthyl corticoides, leur préparation et leur utilisation | |
| CH616435A5 (fr) | ||
| EP0003341B1 (fr) | Prégnanes substitués en positions 11 et 17, leur préparation et leur utilisation pour la préparation de compositions pharmaceutiques | |
| EP0000471A1 (fr) | Nouveaux corticoides, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| CH637407A5 (de) | Verfahren zur herstellung neuer kortikoide. | |
| DE2632678C2 (de) | 6α-Fluor-12α-Halogen-Kortikoide und Verfahren zu ihrer Herstellung | |
| DE2365992A1 (de) | 6 alpha-fluor-17,21-dihydroxy-16 beta-methylpregna-4,9(11)-dien-3,20- dion-17,21-diacetat und verfahren zu dessen herstellung | |
| EP0049783B1 (fr) | D-homo corticoides, leur préparation et leur utilisation | |
| DE2150268B2 (de) | Pregnansäure-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel | |
| DE2150270C3 (de) | Pregnansäure-Derivate und Verfahren zu ihrer Herstellung | |
| DE60112024T2 (de) | Verfahren zur Isomerisierung von 6-Beta-Fluorosteroide zu den entsprechenden 6-Alpha-Derivaten | |
| EP0077541A1 (fr) | Delta-1,3,5-3-chloro-11-bêta, 16-alpha, 17-alpha, 21-tétra-(hydroxy)-pregnane-20-one-16,17-acétonides, procédé pour les préparer et médicaments les contenant | |
| DE2204360C2 (de) | Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| CH625254A5 (fr) | ||
| AT374204B (de) | Verfahren zur herstellung von neuen kortikoiden | |
| DE1468892C (de) | Verfahren zur Herstellung von Steroid-21-apocarnphan-l' -carboxylaten mit lokaler antiinflammatorischer Wirkung | |
| AT362888B (de) | Verfahren zur herstellung von neuen estern von androstadien-17-carbonsaeuren | |
| AT232659B (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
| DE2204361A1 (de) | Neue pregnansaefre-derivate | |
| DE2209298A1 (de) | Neue pregnansaeure-derivate | |
| DE1048915B (de) | Verfahren zur Herstellung von 6-Methyl-9ª‡, 21-difluor-11ª‰, 17ª‡-dioxy-1,4-pregnadien-3,20-dion und dessen 11-Ketoanalogen | |
| CH376503A (de) | Verfahren zur Herstellung neuer Steroide | |
| CH356767A (de) | Verfahren zur Herstellung von Steroiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |